Hasil Pencarian - Postma DS

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day

    Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day oleh Pedersen SE, Prasad N, Goehring UM, Andersson H, Postma DS

    Diterbitkan 2017-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Genetic variation in <it>TIMP1 </it>but not <it>MMPs </it>predict excess FEV<sub>1 </sub>decline in two general population-based cohorts

    Genetic variation in <it>TIMP1 </it>but not <it>MMPs </it>predict excess FEV<sub>1 </sub>decline in two general population-based cohorts oleh Blokstra A, Siedlinski M, Postma DS, van Diemen CC, Smit HA, Boezen HM

    Diterbitkan 2011-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease

    Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease oleh van der Vaart H, Postma DS, Grevink R, Roemer W, ten Hacken NHT

    Diterbitkan 2011-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations

    Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations oleh Calverley PM, Postma DS, Anzueto AR, Make BJ, Eriksson G, Peterson S, Jenkins CR

    Diterbitkan 2016-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    A score to predict short-term risk of COPD exacerbations (SCOPEX)

    A score to predict short-term risk of COPD exacerbations (SCOPEX) oleh Make BJ, Eriksson G, Calverley PM, Jenkins CR, Postma DS, Peterson S, Östlund O, Anzueto A

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials

    The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials oleh Eriksson G, Calverley PM, Jenkins CR, Anzueto AR, Make BJ, Lindberg M, Fagerås M, Postma DS

    Diterbitkan 2017-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

    Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD oleh Calverley PM, Eriksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fagerås M, Postma DS

    Diterbitkan 2016-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD

    Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD oleh Postma DS, Roche N, Colice G, Israel E, Martin RJ, van Aalderen WMC, Grigg J, Burden A, Hillyer EV, von Ziegenweidt J, Gopalan G, Price D

    Diterbitkan 2014-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: